Ilaprazole EC Pellets Manufacturer & Supplier
Acid-suppressive pellets designed for proton pump inhibitor formulations requiring stability and controlled release in gastro-resistant systems.
Product overview
Illaprazole is positioned within the proton pump inhibitor family for formulations requiring robust gastric protection and reproducible release. Rraynex focuses on particle-size control, moisture management, and coating integrity to support capsule filling, multiparticulate dosage forms, and scale-up programs.
Key characteristics
- Controlled pellet processing for consistent handling.
- Enteric protection support for delayed release.
- Suitable for formulation development and commercial supply.
- Technical support for stability, dissolution, and regulatory documentation.
Product specifications
- Product
- Ilaprazole EC Pellets
- Form
- Pellets
- Therapeutic category
- Anti-Ulcerant (PPIs)
- Available strengths
- 15%, 20%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Ilaprazole EC Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities